Variability in the induction of alkaline phosphatase by histone deacetylase inhibitors in bladder and colon cancer cell lines
Journal Title: Journal of Cancer Research & Therapy - Year 2019, Vol 7, Issue 2
Abstract
Induction of alkaline phosphatase activity has provided a convenient marker for differentiation of colon cancer cells. The degree to which different histone deacetylase inhibitors induce alkaline phosphatase and dipeptidyl peptidase activities was compared in bladder and colon cancer cell lines. The objective was to determine whether bladder cancer cell lines that retain activities of the cell surface hydrolases exhibit regulatory effects similar to those previously observed in colon cancer cells. Effects of histone deacetylase inhibitors on growth and alkaline phosphatase and dipeptidyl peptidase activities were studied in three human colon cancer cells and three bladder cancer cell lines. Growth inhibition was observed with all the histone deacetylase inhibitors that were examined. There was variability in the induction of enzyme activity with different histone deacetylase inhibitors but when induction was observed it was greater for alkaline phosphatase than for dipeptidyl peptidase. The data suggested that regulation of alkaline phosphatase and dipeptidyl peptidase activities by histone deacetylase inhibitors can be similar in bladder and colon cancer cells. However, the functional role of the enzyme activities in bladder-derived cells remains to be established.
Authors and Affiliations
Michael A. Lea, Elizabeth Batista, Lauran Cue, Charles desBordes
Split-course chemoradiotherapy with S-1, a novel oral fluorouracil, and cisplatin for distant metastases of oesophageal cancer stage IVb
Objectives: To evaluate the efficacy and safety of split-course chemoradiotherapy with S-1, a novel oral fluorouracil, together with cisplatin in patients with distant oesophageal cancer stage IVb metastasis. Methods: Fo...
Economic evaluation of monoclonal antibody in the management of colorectal cancer
Objective: This study aims to determine the cost of colorectal cancer (CRC) management and compare the cost effectiveness of cetuximab and bevacizumab in the management of CRC. Method: This economic evaluation study from...
Half-times of irradiation recovery in accelerated partialbreast irradiation: Incomplete recovery as a potentially dangerous enhancer of radiation damage
Purpose: To compare clinical results from accelerated partial breast irradiation with predictions from different half-times of recovery of radiation damage. Method: Three published results of excessive late complications...
miRNA array analysis determines miR-205 is overexpressed in head and neck squamous cell carcinoma and enhances cellular proliferation
MicroRNAs (miRNAs) play a critical role in cell cycle and pro-survival signal regulation. Consequently, their deregulation can enhance tumorigenesis and cancer progression. In the current investigation, we determined whe...
HTLV-1 can be involved in acceleration of different nonhematological cancers
In the past two decades it has been found that viral proteins might contribute to activation of numerous pathways involved in different types of cancer. Human T-lymphotropic virus 1 (HTLV-1), well known as a cause of T-c...